Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Med Sci Monit ; 22: 2347-56, 2016 Jul 06.
Artigo em Inglês | MEDLINE | ID: mdl-27381636

RESUMO

BACKGROUND Hepatitis C virus (HCV) infection, as a major cause of chronic hepatic diseases, is always accompanied with an abnormality of lipid metabolism. The aim of this study was to investigate the pathogenic role of free fatty acids (FFA) in human HCV infection. MATERIAL AND METHODS Peripheral blood lipid indexes among HCV patients with different viral loads (199 samples) and healthy donors (80 samples) were detected by clinical biochemistry tests. HCV replication and the expression of growth arrest and DNA-damage-inducible gene 45-α (GADD45α) in Huh7 cells and clinical samples were quantified by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting. Lipid accumulation in Huh7 cells was detected by immunofluorescence. RESULTS In this study, we found that FFA showed a significant positive correlation with viral load in peripheral blood of HCV patients, but not total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), or low-density lipoprotein cholesterol (LDL-C). GADD45α expression in HCV patients dramatically decreased with the increase of viral load. In Huh7 cells, FFA treatment significantly enhanced HCV replication. HCV infection inhibited GADD45α expression, and this effect was further enhanced with the presence of FFA treatment. Ectopic expression of GADD45α in HCV-infected Huh7 cells markedly inhibited the absorption of FFA and HCV replication. However, FFA significantly elevated GADD45α expression without HCV infection. CONCLUSIONS These results demonstrated that HCV down-regulates GADD45α expression to enhance FFA absorption and thus facilitate its replication. GADD45α is an essential mediator for the pathogenesis of HCV infection. Thus, our study provides potential clues in the search for novel therapeutics and fatty lipid control options for HCV patients.


Assuntos
Proteínas de Ciclo Celular/biossíntese , Ácidos Graxos não Esterificados/sangue , Hepacivirus/fisiologia , Hepatite C Crônica/sangue , Proteínas Nucleares/biossíntese , Adolescente , Adulto , Idoso , Proteínas de Ciclo Celular/genética , Linhagem Celular , Regulação para Baixo , Feminino , Hepacivirus/metabolismo , Hepatite C Crônica/genética , Hepatite C Crônica/virologia , Hepatócitos/metabolismo , Hepatócitos/virologia , Humanos , Metabolismo dos Lipídeos , Lipoproteínas HDL/sangue , Lipoproteínas HDL/metabolismo , Masculino , Pessoa de Meia-Idade , Proteínas Nucleares/genética , Triglicerídeos/sangue , Carga Viral , Replicação Viral/fisiologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA